ITGAX and neoplasm: A subsequent study reported that CD8+ T cell activation coincided with CD11c upregulation, and that the majority of the tumor-infiltrating CD8+ T cells were CD11c+ in ovalbumin and poly(I:C)-treated mice, reflecting tumoricidal efficacy (16).